In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 8, Issue 11, 2014, Pages 1539-1547

  Maranville, Joseph C ^a   Micic, Dejan ^a   Hanauer, Stephen B ^a   Di Rienzo, Anna ^a   Kupfer, Sonia S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Crohn's disease; ; Cytokines; ; Pharmacology; ; Precision medicine; Ulcerative colitis;

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; T LYMPHOCYTE; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADAPTIVE IMMUNITY; CELL CULTURE; CELL PROLIFERATION; COLITIS, ULCERATIVE; DRUG EFFECTS; DRUG RESISTANCE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADAPTIVE IMMUNITY; ADULT; ANTIGENS, CD28; ANTIGENS, CD3; BIOMARKERS; CELL PROLIFERATION; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84927799183     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.06.013     Document Type: Article

References (32)

1. Ford A.C., Bernstein C.N., Khan K.J., Abreu M.T., Marshall J.K., Talley N.J., et al. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011, 106(4):590-599. [quiz 600].
2. Cohen R.D. How should we treat severe acute steroid-refractory ulcerative colitis?. Inflamm Bowel Dis 2009, 15(1):150-151.
3. Creed T.J., Probert C.S. Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies. Aliment Pharmacol Ther 2007, 25(2):111-122.
4. De Iudicibus S., Franca R., Martelossi S., Ventura A., Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011, 17(9):1095-1108.
5. Sidoroff M., Kolho K.L. Glucocorticoid sensitivity in inflammatory bowel disease. Ann Med 2012, 44(6):578-587.
6. Munkholm P., Langholz E., Davidsen M., Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994, 35(3):360-362.
7. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121(2):255-260.
8. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Pineiro A., Wei L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999, 130(6):487-495.
9. Chan M.T., Leung D.Y., Szefler S.J., Spahn J.D. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998, 101(5):594-601.
10. Duffy D.L., Martin N.G., Battistutta D., Hopper J.L., Mathews J.D. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990, 142(6 Pt 1):1351-1358.
11. Reinisch W., Gasche C., Wyatt J., Moser G., Lochs H., Vogelsang H., et al. Steroid dependency in Crohn's disease. Lancet 1995, 345(8953):859.
12. Lindgren S.C., Flood L.M., Kilander A.F., Lofberg R., Persson T.B., Sjodahl R.I. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998, 10(10):831-835.
13. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, 2(4947):1041-1048.
14. Hearing S.D., Norman M., Probert C.S., Haslam N., Dayan C.M. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999, 45(3):382-388.
15. Langhoff E., Ladefoged J., Jakobsen B.K., Platz P., Ryder L.P., Svejgaard A., et al. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1986, 1(8493):1296-1297.
16. Kirkham B.W., Corkill M.M., Davison S.C., Panayi G.S. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses. J Rheumatol 1991, 18(6):821-825.
17. Corrigan C.J., Brown P.H., Barnes N.C., Szefler S.J., Tsai J.J., Frew A.J., et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991, 144(5):1016-1025.
18. Lee R.W., Creed T.J., Schewitz L.P., Newcomb P.V., Nicholson L.B., Dick A.D., et al. CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids. J Immunol 2007, 179(11):7941-7948.
19. Lee R.W., Schewitz L.P., Nicholson L.B., Dayan C.M., Dick A.D. Steroid refractory CD4+ T cells in patients with sight-threatening uveitis. Invest Ophthalmol Vis Sci 2009, 50(9):4273-4278.
20. Murphy S.F., Kwon J.H., Boone D.L. Novel players in inflammatory bowel disease pathogenesis. Curr Gastroenterol Rep 2012, 14(2):146-152.
21. Jostins L., Ripke S., Weersma R.K., Duerr R.H., Mcgovern D.P., Hui K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491(7422):119-124.
22. Knutson C.G., Mangerich A., Zeng Y., Raczynski A.R., Liberman R.G., Kang P., et al. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A 2013, 110(26):E2332-E2341.
23. Mazlam M.Z., Hodgson H.J. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992, 33(6):773-778.
24. Hew M., Bhavsar P., Torrego A., Meah S., Khorasani N., Barnes P.J., et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174(2):134-141.
25. Franchimont D., Louis E., Dupont P., Vrindts-Gevaert Y., Dewe W., Chrousos G., et al. Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig Dis Sci 1999, 44(6):1208-1215.
26. Reed G.F., Lynn F., Meade B.D. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002, 9(6):1235-1239.
27. Strober W., Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 2011, 4(5):484-495.
28. Rivas M.A., Beaudoin M., Gardet A., Stevens C., Sharma Y., Zhang C.K., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43(11):1066-1073.
29. Cossu A., Biancone L., Ascolani M., Pallone F., Boirivant M. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-gamma production associate with drug response in patients with Crohn's Disease. J Crohns Colitis 2013, 7(6):441-450.
30. Mookerjee B.K. Functional characteristics of monocytes. 1. Essential role in the transformational response of human blood lymphocytes to phytomitogens. Transplantation 1977, 23(1):22-28.
31. Bettiol J., Bartsch P., Louis R., De Groote D., Gevaerts Y., Louis E., et al. Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy 2000, 55(12):1134-1141.
32. Maranville J.C., Baxter S.S., Witonsky D.B., Chase M.A., Di Rienzo A. Genetic Mapping with Multiple Levels of Phenotypic Information Reveals Determinants of Lymphocyte Glucocorticoid Sensitivity. Am J Hum Genet 2013, 93(4):735-743.